Leading International Fungal Infection (LIFE) has been supported by the 20 year old UK charity the Fungal Infection Trust. LIFE is dedicated to improving health in those with fungal disease (infection and allergy) through education. The overall goal is to greatly improve fungal infection outcomes in patients through healthcare professional awareness, diagnostic acumen, improved diagnosis and selection of the appropriate antifungal therapies, worldwide.
Jenny Bartholomew, Editor in Chief and lead writer.
Jenny has been Senior Editor and writer for the Aspergillus Web educational resources for the past 15 years. She previously worked in Oncology research at Christie's Hospital, Manchester, UK and in connective tissue research & Rheumatoid Arthritis at Manchester University, UK and as a lecturer at Monash University, Melbourne.
Her expertise encompasses all aspects of fungal diseases working within the University Hospital of South Manchester and also the National Aspergillosis Centre. Jenny launched the LIFE-worldwide.org website in 2012 & GAFFI.org in 2013. She continues her role as Editor in Chief and lead writer for both resources as they continue to develop.
LIFE is led by Professor David Denning who has been caring for patients with fungal infection for over 25 years. He leads the National Aspergillosis Centre, UK (the first national clinical centre devoted to any fungal disease) and manages a clinical and laboratory research team.
He founded the Aspergillus Website (the encyclopaedic on-line resource), F2G Ltd (now developing a novel antifungal agent) and Myconostica Ltd (which pioneered commercial development of molecular testing for fungi) and is the Scientific Director of the Fungal Infection Trust, a UK charitable foundation.
He has advised and given educational talks on behalf of multiple pharmaceutical and diagnostic companies. He has published more than 500 papers, books and book chapters and lectures worldwide. He has successfully lead many major international collaborative science, diagnostic and treatment projects and clinical guidelines, with subsequent publication in Nature, the New England Journal of Medicine and the Lancet. He is President of the Global Action Fund for Fungal Infections (GAFFI.org) which has a mission to greatly improve outcomes for patients with fungal infections, through greater understanding of the burden of fungal diseases, advocacy for universal access to fungal diagnostic testing and antifungal therapies, and enhancing clinical skills through education.